Cost-Effectiveness of Different Strategies for Selecting and Treating Individuals at Increased Risk of Osteoporosis or Osteopenia: A Systematic Review
- 30 April 2012
- journal article
- review article
- Published by Elsevier BV in Value in Health
- Vol. 15 (2), 284-298
- https://doi.org/10.1016/j.jval.2011.11.030
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Compliance and persistence with osteoporosis medications: A critical review of the literatureReviews in Endocrine and Metabolic Disorders, 2010
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Shifting the focus in fracture prevention from osteoporosis to fallsBMJ, 2008
- The cost-effectiveness of risedronate treatment in Japanese women with osteoporosisJournal of Bone and Mineral Metabolism, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal OsteoporosisPharmacoEconomics, 2008
- The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of OsteoporosisPharmacoEconomics, 2007
- Costs and quality of life associated with osteoporosis-related fractures in SwedenOsteoporosis International, 2005
- Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent FracturesArchives of Internal Medicine, 2004
- Accounting for future costs in medical cost-effectiveness analysisJournal of Health Economics, 1997